FHTXVSMRNA• 12 Months (Normalized)
FHTX vs MRNA (Foghorn Therapeutics Inc. vs Moderna Inc.)
Showing Closing Date Range from Oct 6, 2025 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
FHTX Performance $1.97
-56.51%
Foghorn Therapeutics Inc.
Normalized Baseline0.00%
MRNA Performance $187.46
+580.68%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
-637.19 pts
MRNA outperforming by 637.19 percentage points
FHTXMRNA
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
FHTX MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | FHTX Price | FHTX Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $1.97 | -56.51% | $187.46 | +580.68% | -637.19% |
| Oct 05, 2026 | $2.00 | -55.85% | $203.21 | +637.87% | -693.72% |
| Oct 02, 2026 | $2.02 | -55.41% | $190.01 | +589.94% | -645.35% |
| Oct 01, 2026 | $2.92 | -35.54% | $188.94 | +586.06% | -621.60% |
| Sep 30, 2026 | $3.57 | -21.19% | $192.57 | +599.24% | -620.43% |
| Sep 29, 2026 | $- | $203.46 | +638.78% | - | |
| Sep 28, 2026 | $- | $197.28 | +616.34% | - | |
| Sep 25, 2026 | $3.54 | -21.85% | $198.88 | +622.15% | -644.00% |
| Sep 24, 2026 | $3.60 | -20.53% | $- | - | |
| Sep 23, 2026 | $3.87 | -14.57% | $182.11 | +561.26% | -575.83% |
| Sep 22, 2026 | $4.24 | -6.40% | $182.56 | +562.89% | -569.29% |
| Sep 21, 2026 | $4.15 | -8.39% | $172.94 | +527.96% | -536.35% |
| Sep 18, 2026 | $4.14 | -8.61% | $154.04 | +459.33% | -467.94% |
| Sep 17, 2026 | $4.20 | -7.28% | $158.07 | +473.97% | -481.25% |
| Sep 16, 2026 | $4.17 | -7.95% | $145.62 | +428.76% | -436.71% |
Page 1 of 17